IDEXX Laboratories logo
IDEXX Laboratories IDXX
$ 700.99 -0.46%

Quarterly report 2025-Q3
added 11-03-2025

report update icon

IDEXX Laboratories Cash Flow 2011-2025 | IDXX

Annual Cash Flow IDEXX Laboratories

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

929 M 907 M 543 M 756 M 648 M 459 M 400 M 373 M - - 236 M 246 M 222 M 218 M

Depreciation & Amortization

130 M 115 M 112 M 105 M 96 M 88 M 83.2 M 83.1 M 78.2 M 69 M 58.9 M 54.6 M 52.4 M 48.2 M

Accounts Payables

114 M 111 M 59.4 M 64.4 M 45.6 M 72.2 M 69.5 M 67 M 60.1 M 52.6 M 44.7 M 29.9 M 35.3 M 36.6 M

Accounts Receivables

474 M 457 M 401 M 368 M 331 M 269 M 249 M 235 M 204 M 188 M 152 M 158 M 138 M 141 M

Total Inventories

382 M 380 M 368 M 269 M 210 M 195 M 173 M 164 M 158 M 189 M 160 M 133 M 141 M 133 M

All numbers in USD currency

Quarterly Cash Flow IDEXX Laboratories

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - 238 M - - - 199 M - - - 184 M - 370 M - 115 M - 546 M - 124 M - 429 M 236 M 27.9 M - 304 M 171 M 34.4 M - 264 M 154 M 34.9 M - 252 M 141 M 31.3 M - - - - - - - -14.6 M - - 115 M 33.5 M - 181 M 102 M 21.1 M - 153 M 78.8 M 15.2 M - 164 M 88.3 M 25.2 M

Depreciation & Amortization

- - 34.1 M - - - 29.9 M - - - 28.3 M - 83.2 M - 26.5 M - 76.9 M - 25.1 M - 71.4 M 46.8 M 23.2 M - 65.4 M 43 M 21.4 M - 62.6 M 41.7 M 20.8 M - 61.6 M 40.9 M 20.3 M - 58 M 38.2 M 18.5 M - 51.2 M 32.9 M 16.2 M - 43.6 M 28.1 M 13.4 M - 41.1 M 27.4 M 13.5 M - 38.5 M 25.7 M 12.7 M - 35.4 M 23.3 M 11.5 M

Accounts Payables

122 M 117 M 120 M 114 M 111 M 117 M 117 M 111 M 113 M 108 M 118 M 110 M 110 M - 121 M 116 M 86.7 M 93 M 87.2 M 74.6 M 74.6 M 74.6 M 74.6 M 72.2 M 72.2 M 72.2 M 72.2 M 69.5 M 69.5 M 69.5 M 69.5 M 67 M 67 M 67 M 67 M 60.1 M 60.1 M 60.1 M 60.1 M 52.6 M 52.6 M 52.6 M 52.6 M 44.7 M 44.7 M 44.7 M 44.7 M 29.9 M 29.9 M 29.9 M 29.9 M 35.3 M 35.3 M 35.3 M 35.3 M 36.6 M 36.6 M 36.6 M 36.6 M

Accounts Receivables

567 M 561 M 527 M 474 M 511 M 534 M 507 M 457 M 453 M 462 M 446 M 401 M 388 M - 402 M 368 M 377 M 382 M 382 M 331 M 331 M 331 M 331 M 269 M 269 M 269 M 269 M 249 M 249 M 249 M 249 M 235 M 235 M 235 M 235 M 204 M 204 M 204 M 204 M 188 M 188 M 188 M 188 M 152 M 152 M 152 M 152 M 158 M 158 M 158 M 158 M 138 M 138 M 138 M 138 M 141 M 141 M 141 M 141 M

Total Inventories

392 M 393 M 396 M 382 M 390 M 380 M 391 M 380 M 394 M 395 M 391 M 368 M 355 M - 302 M 269 M 258 M 241 M 226 M 210 M 210 M 210 M 210 M 195 M 195 M 195 M 195 M 173 M 173 M 173 M 173 M 164 M 164 M 164 M 164 M 158 M 158 M 158 M 158 M 189 M 189 M 189 M 189 M 160 M 160 M 160 M 160 M 133 M 133 M 133 M 133 M 141 M 141 M 141 M 141 M 133 M 133 M 133 M 133 M

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company IDEXX Laboratories, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Diagnostics research sector

Issuer Price % 24h Market Cap Country
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 17.13 1.66 % $ 99.4 M israelIsrael
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 12.15 2.14 % $ 345 M israelIsrael
DexCom DexCom
DXCM
$ 66.06 -1.34 % $ 25.5 B usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 101.57 0.07 % $ 18.8 B usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 16.0 1.59 % $ 172 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.56 -3.7 % $ 1.98 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 38.95 0.82 % $ 1.08 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 227.29 0.42 % $ 166 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 26.94 -0.74 % $ 815 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 408.65 1.08 % $ 29.9 B schweizSchweiz
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
NeoGenomics NeoGenomics
NEO
$ 12.15 2.53 % $ 1.54 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 6.84 -0.36 % $ 1.48 B usaUSA
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 19.9 -3.21 % $ 1.07 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 2.12 - $ 538 M usaUSA
Celcuity Celcuity
CELC
$ 101.74 -3.33 % $ 4.01 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 3.35 -6.42 % $ 107 K usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 26.46 -0.62 % $ 20 B niderlandNiderland
Co-Diagnostics Co-Diagnostics
CODX
$ 0.3 -13.39 % $ 8.8 M usaUSA
Precipio Precipio
PRPO
$ 24.67 -1.2 % $ 32 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 224.13 0.84 % $ 40.6 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
$ 45.14 -0.21 % $ 10 B niderlandNiderland
Guardant Health Guardant Health
GH
$ 103.55 1.45 % $ 12.7 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Sotera Health Company Sotera Health Company
SHC
$ 16.76 -0.42 % $ 4.74 B usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
$ 49.79 -4.25 % $ 2 B usaUSA
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
$ 574.27 0.46 % $ 219 B usaUSA
Illumina Illumina
ILMN
$ 134.66 -0.16 % $ 21.4 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 197.59 2.36 % $ 10.2 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
$ 0.96 -10.6 % $ 61.9 M irlandaIrlanda
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
$ 31.39 1.47 % $ 1.88 B usaUSA
Quotient Limited Quotient Limited
QTNT
- -11.32 % $ 1.1 M schweizSchweiz
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 184.04 0.81 % $ 20.4 B usaUSA
Biodesix Biodesix
BDSX
$ 7.63 -2.8 % $ 989 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 7.07 -2.01 % $ 641 M usaUSA